Neurofibromatosis sort 1 nonetheless lacks established therapy choices geared toward controlling the development of neurofibromas in addition to efficient remedy for the neurogenic itch related to the illness. We report the case of a 30-year-old Caucasian lady with sort 1 neurofibromatosis coexisting with extreme refractory atopic dermatitis.
Dupilumab, a novel anti-IL-Four receptor alpha monoclonal antibody, the primary biologic agent authorized for atopic dermatitis, was the drug of alternative on this case. The incidence of GISTs in NF1 affected person is round 6-7%; nevertheless, concomitant presence of a number of GISTs is uncommon. CECT of stomach together with histopathological and immunohistochemistry research are diagnostic. The administration of GIST consists of surgical and adjuvant remedy strategies primarily based on the tumorigenesis and recurrent threat stratification.
We noticed remission of atopic dermatitis and a outstanding discount within the dimension and swelling of neurofibromas and within the associated pruritus, that grew to become evident after one month of therapy. After 18 months of remedy, no new neurofibromas have been detected and preexistent lesions confirmed no improve in dimension. These findings are according to the speculation that dupilumab, a potent anti-inflammatory drug, could have a optimistic impact on sort 1 neurofibromatosis by stopping the development of preexisting neurofibromas and the onset of recent lesions.
The affiliation between gastrointestinal stromal tumor (GIST), mesenchymal tumor arising from the interstitial cells of cajal and Neurofibromatosis sort 1 (NF1), an autosomal dominant illness has been reported within the literature. GIST in NF1 sufferers are a number of and positioned within the small gut. Tumorigenesis in NF1 related GIST is totally different to that of sporadic GIST and therefore the therapy. Right here we report a uncommon case of an NF1 affected person with a number of jejunal GISTs.
An Unusual Incidence of Pulmonary Hypertension Related With Neurofibromatosis Sort 1: A Case Report
Pulmonary hypertension (PH) is commonly a troublesome situation to diagnose, because it happens insidiously and is a prognosis of exclusion. Sufferers with neurofibromatosis sort 1 (NFT1) have been related to extreme exacerbations of PH. To our information, lower than 20 circumstances of PH in NFT1 sufferers have been reported. Nevertheless, the severity of presenting signs requires physicians to pay attention to this affiliation and pursue the suitable diagnostic workup. In our report, we current a 54-year-old NFT1 affected person who offered with worsening dyspnea secondary to PH, which was being handled with trepostanil and macitetan. She required a proper coronary heart catheterization to evaluate her pulmonary artery pressures (which remained elevated).
She was positioned on tadalafil along with trepostanil and macitetan and famous important decision of her signs. Additional research are required to discover the affiliation between PH and NFT1 and look at the efficacy of triple remedy with endothelin receptor antagonists, phosphodiesterase 5 inhibitors, and parenteral prostanoids within the preliminary therapy of PH within the aforementioned affected person inhabitants. n spite of the excessive detection charge for PVs in NF1 and NF2 (over 90% of non-mosaic germline variants could be recognized by routine genetic screening) underlying PVs for a proportion of medical circumstances stay undetected.
Plenty of variants of unsure significance (VUS) have been noticed for every dysfunction, a lot of them positioned in non-coding, regulatory or intergenic areas. Right here we summarise non-coding variants on this group of genes and focus on their established or potential position within the pathogenesis of NF1, NF2 and schwannomatosis. This text is protected by copyright. All rights reserved. We enrolled 60 sufferers with NF1 and 50 wholesome controls with no historical past of NF1. Sufferers underwent a full psychiatric analysis. Psychiatric prognosis was made in accordance with Diagnostic and Statistical Guide of Psychological Issues, fifth version (DSM-5) standards.

Sufferers and controls underwent a collection of psychometric measures, particularly the Columbia Suicide Severity Ranking Scale, the Beck Hopelessness Scale, the Italian Perceived Incapacity Scale and the Beck Despair Stock. The next proportion of non-NF2 schwannomatosis circumstances don’t have any detected PV, with PVs at present solely recognized in round 70 – 86% of familial circumstances and 30 – 40% of non-NF2 sporadic schwannomatosis circumstances.
Artificial MRI in Neurofibromatosis Sort 1
Artificial MRI allows the technology of assorted contrast-weighted photographs and quantitative information in an inexpensive scanning time. We aimed to make use of artificial MRI to evaluate the detection and underlying tissue traits of focal areas of sign depth and normal-appearing mind parenchyma and morphometric alterations within the brains of sufferers with neurofibromatosis sort 1.
Standard MR imaging and artificial MRI have been prospectively obtained from 19 sufferers with neurofibromatosis sort 1 and 18 wholesome controls. Two neuroradiologists independently evaluated focal areas of sign depth on each typical MR imaging and artificial MRI. Moreover, routinely segmented quantity calculations of the mind in each teams and quantitative evaluation of myelin, together with the focal areas of sign depth and normal-appearing mind parenchyma, of sufferers with neurofibromatosis sort 1 have been carried out utilizing artificial MRI.
Sulfo-NHS-LC-Biotin |
|
A8003-1000 |
ApexBio |
1 g |
EUR 686.4 |
|
Description: Sulfo-NHS-LC-biotin (Sulfosuccinimidyl 6-(biotinamido) Hexanoate) is an amine-reactive biotinylation agent. |
Sulfo-NHS-LC-Biotin |
|
MBS3840687-100mg |
MyBiosource |
100mg |
EUR 985 |
Sulfo-NHS-LC-Biotin |
|
MBS3840687-5x100mg |
MyBiosource |
5x100mg |
EUR 4420 |
Sulfo-NHS-LC-Biotin |
|
MBS5784242-100mg |
MyBiosource |
100(mg |
EUR 345 |
Sulfo-NHS-LC-Biotin |
|
MBS5784242-1g |
MyBiosource |
1g |
EUR 1045 |
Sulfo-NHS-LC-Biotin |
|
MBS5784242-5x1g |
MyBiosource |
5x1g |
EUR 4560 |
Sulfo-NHS-LC-Biotin |
|
T34744-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-LC-Biotin |
Sulfo-NHS-LC-Biotin |
|
T34744-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
|
|
Description: Sulfo-NHS-LC-Biotin |
Sulfo-NHS-LC-Biotin |
|
T34744-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-LC-Biotin |
Sulfo-NHS-LC-Biotin |
|
T34744-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-LC-Biotin |
Sulfo-NHS-LC-Biotin |
|
T34744-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-LC-Biotin |
Sulfo-NHS SS Biotin |
|
41900164-1 |
Bio-WORLD |
100 mg |
Ask for price |
|
|
Sulfo-NHS-LC-Biotin Kit |
|
K1001-10 |
ApexBio |
10 reactions |
EUR 181.6 |
|
|
|
Description: Biotinylation Reagents|Amine Biotinylation Reagents#Biotinylation reagents and kits|Amine Biotinylation Reagents and Kits#Labels and tags|Biotinylation Reagents#Biotinylation reagents and kits |
Sulfo-NHS-LC-Biotin sodium |
|
MBS5799838-100mg |
MyBiosource |
100(mg |
EUR 315 |
Sulfo-NHS-LC-Biotin sodium |
|
MBS5799838-10mg |
MyBiosource |
10(mg |
EUR 195 |
Sulfo-NHS-LC-Biotin sodium |
|
MBS5799838-50mg |
MyBiosource |
50(mg |
EUR 220 |
Sulfo-NHS-LC-Biotin sodium |
|
T39340-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-LC-Biotin sodium |
Sulfo-NHS-LC-Biotin sodium |
|
T39340-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
|
|
Description: Sulfo-NHS-LC-Biotin sodium |
Sulfo-NHS-LC-Biotin sodium |
|
T39340-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-LC-Biotin sodium |
Sulfo-NHS-LC-Biotin sodium |
|
T39340-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-LC-Biotin sodium |
Sulfo-NHS-LC-Biotin sodium |
|
T39340-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-LC-Biotin sodium |
Sulfo-NHS LC SPDP |
|
21810024-1 |
Bio-WORLD |
100 mg |
EUR 338.64 |
|
|
Biotin-LC-LC-NHS |
|
2346-1000 |
Biovision |
each |
EUR 2010 |
Biotin-LC-LC-NHS |
|
2346-250 |
Biovision |
each |
EUR 705.6 |
Biotin-LC-LC-NHS |
|
2346-50 |
Biovision |
each |
EUR 235.2 |
Biotin-LC-LC-NHS |
|
2346-5000 |
Biovision |
each |
Ask for price |
Biotin-LC-LC-NHS |
|
MBS5801169-100mg |
MyBiosource |
100(mg |
EUR 515 |
Biotin-LC-LC-NHS |
|
MBS5801169-5x100mg |
MyBiosource |
5x100mg |
EUR 2170 |
Biotin-LC-LC-NHS |
|
T41026-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
|
|
Description: Biotin-LC-LC-NHS |
Biotin-LC-LC-NHS |
|
T41026-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
|
|
Description: Biotin-LC-LC-NHS |
Biotin-LC-LC-NHS |
|
T41026-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
|
|
Description: Biotin-LC-LC-NHS |
Biotin-LC-LC-NHS |
|
T41026-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
|
|
Description: Biotin-LC-LC-NHS |
Sulfo-NHS-Biotin |
|
2322-250 |
Biovision |
each |
EUR 836.4 |
Sulfo-NHS-Biotin |
|
2322-50 |
Biovision |
each |
EUR 274.8 |
Sulfo-NHS-Biotin |
|
2322-set |
Biovision |
each |
EUR 222 |
Sulfo-NHS-Biotin |
|
A8001-100 |
ApexBio |
100 mg |
EUR 60 |
|
|
|
Description: Biotinylation Reagents|Amine Biotinylation Reagents |
Sulfo-NHS-Biotin |
|
A8001-1000 |
ApexBio |
1 g |
EUR 588 |
|
Description: Sulfo-NHS-Biotin (N-Hydroxysulfosuccinimidobiotin) is an amine-reactive biotinylation reagent. The most common amine-reactive biotinylation reagents can be divied into two basic types, N-hydroxysuccinimide (NHS) esters and carboxylates. |
Sulfo-NHS-Biotin |
|
MBS3840686-100mg |
MyBiosource |
100mg |
EUR 220 |
Sulfo-NHS-Biotin |
|
MBS3840686-5x1g |
MyBiosource |
5x1g |
EUR 3870 |
Sulfo-NHS-Biotin |
|
MBS5756281-100mg |
MyBiosource |
100mg |
EUR 290 |
Sulfo-NHS-Biotin |
|
MBS5756281-10mg |
MyBiosource |
10mg |
EUR 155 |
Sulfo-NHS-Biotin |
|
MBS5756281-25mg |
MyBiosource |
25mg |
EUR 195 |
Sulfo-NHS-Biotin |
|
MBS5756281-50mg |
MyBiosource |
50mg |
EUR 240 |
Sulfo-NHS-Biotin |
|
MBS5756281-5mg |
MyBiosource |
5mg |
EUR 145 |
Sulfo-NHS-Biotin |
|
T19952-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-Biotin |
Sulfo-NHS-Biotin |
|
T19952-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-Biotin |
Sulfo-NHS-Biotin |
|
T19952-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-Biotin |
Sulfo-NHS-Biotin |
|
T19952-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-Biotin |
Biotin-NHS LC |
|
41400016-1 |
Bio-WORLD |
100 mg |
EUR 171.09 |
|
|
LC-NHS-(+)-Biotin |
|
20-abx185861 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Biotin-LC-NHS |
|
2345-1000 |
Biovision |
each |
EUR 1201.2 |
Biotin-LC-NHS |
|
2345-250 |
Biovision |
each |
EUR 502.8 |
Biotin-LC-NHS |
|
2345-50 |
Biovision |
each |
EUR 170.4 |
Sulfo-NHS-Biotin Kit |
|
K1005-10 |
ApexBio |
10 reactions |
EUR 181.6 |
|
|
|
Description: Biotinylation Reagents|Amine Biotinylation Reagents#Biotinylation reagents and kits|Amine Biotinylation Reagents and Kits#Labels and tags|Biotinylation Reagents#Biotinylation reagents and kits |
Sulfo-NHS-Biotin (sodium) |
|
HY-136964 |
MedChemExpress |
10 mg |
EUR 124.46 |
|
Description: Sulfo-NHS-Biotin (sodium) stongly label single SDS-2ME soluble cuticular protein[1]. |
Sulfo-NHS-SS-Biotin |
|
2323-100 |
Biovision |
each |
EUR 379.2 |
Sulfo-NHS-SS-Biotin |
|
2323-50 |
Biovision |
each |
EUR 255.6 |
Sulfo-NHS-SS-Biotin |
|
2323-set |
Biovision |
each |
EUR 274.8 |
Sulfo-NHS-SS-Biotin |
|
A8005-100 |
ApexBio |
100 mg |
EUR 144 |
|
|
|
Description: Biotinylation Reagents|Amine Biotinylation Reagents |
Sulfo-NHS-SS-Biotin |
|
A8005-1000 |
ApexBio |
1 g |
EUR 1034.4 |
|
Description: Sulfo-NHS-SS-biotin(sulfosuccinimidyl-20(biotinamido)ethyl-1,3-dithiopropionate) is a long-chain cleavable amine-reactive biotinylation reagent. |
Sulfo-NHS |
|
21960000-1 |
Bio-WORLD |
500 mg |
EUR 123.73 |
|
|
sulfo-NHS |
|
20-abx184386 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Sulfo-NHS-SS-Biotin Kit |
|
K1006-10 |
ApexBio |
10 reactions |
EUR 181.6 |
|
|
|
Description: Biotinylation Reagents|Amine Biotinylation Reagents#Biotinylation reagents and kits|Amine Biotinylation Reagents and Kits#Labels and tags|Biotinylation Reagents#Biotinylation reagents and kits |
Sulfo-NHS-SS-11-Biotin |
|
A8015-100 |
ApexBio |
100 mg |
EUR 76 |
|
|
|
Description: Protein Labeling|Biotinylation Reagents |
Sulfo-NHS-SS-11-Biotin |
|
A8015-1000 |
ApexBio |
1 g |
EUR 560 |
|
|
|
Description: Protein Labeling|Biotinylation Reagents |
Sulfo-NHS-SS-Biotin (sodium) |
|
HY-111496 |
MedChemExpress |
10 mg |
EUR 487.02 |
|
Description: Sulfo-NHS-SS-biotin is a long-chain cleavable and cell-impermeant amine-reactive biotinylation reagent. Sulfo-NHS-SS-biotin can be used for the labeling and purifying of cell-surface protein[1]. |
Sulfo-NHS-SS-Biotin sodium |
|
MBS5771776-100mg |
MyBiosource |
100mg |
EUR 285 |
Sulfo-NHS-SS-Biotin sodium |
|
MBS5771776-10mg |
MyBiosource |
10mg |
EUR 150 |
Sulfo-NHS-SS-Biotin sodium |
|
MBS5771776-50mg |
MyBiosource |
50mg |
EUR 215 |
Sulfo-NHS-SS-Biotin sodium |
|
MBS5771776-5x100mg |
MyBiosource |
5x100mg |
EUR 1130 |
Sulfo-NHS-SS-Biotin sodium |
|
T19061-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-SS-Biotin sodium |
Sulfo-NHS-SS-Biotin sodium |
|
T19061-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
|
|
Description: Sulfo-NHS-SS-Biotin sodium |
Sulfo-NHS-SS-Biotin sodium |
|
T19061-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-SS-Biotin sodium |
Sulfo-NHS-SS-Biotin sodium |
|
T19061-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-SS-Biotin sodium |
Sulfo-NHS-SS-Biotin sodium |
|
T19061-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-SS-Biotin sodium |
Succinimidyl-6-(biotinamido) Hexanoate (NHS-LC-BIOTIN) |
|
MBS6026068-100mg |
MyBiosource |
100(mg |
EUR 485 |
Succinimidyl-6-(biotinamido) Hexanoate (NHS-LC-BIOTIN) |
|
MBS6026068-250mg |
MyBiosource |
250mg |
EUR 765 |
Succinimidyl-6-(biotinamido) Hexanoate (NHS-LC-BIOTIN) |
|
MBS6026068-5x250mg |
MyBiosource |
5x250mg |
EUR 3300 |
Sulfo-Cyanine 3 NHS ester |
|
263 |
AAT Bioquest |
10 mg |
EUR 570 |
|
Description: A variety of cyanine dyes has been used to label biological molecules for fluorescence imaging and other fluorescence-based biochemical analysis. |
Sulfo-Cyanine 3 NHS ester |
|
263-10mg |
AAT Bioquest |
10 mg |
EUR 558 |
|
|
|
Description: A variety of cyanine dyes has been used to label biological molecules for fluorescence imaging and other fluorescence-based biochemical analysis. |
Sulfo-Cyanine 3 NHS ester |
|
264 |
AAT Bioquest |
50 mg |
EUR 1667 |
|
Description: A variety of cyanine dyes has been used to label biological molecules for fluorescence imaging and other fluorescence-based biochemical analysis. |
Sulfo-Cyanine 3 NHS ester |
|
264-50mg |
AAT Bioquest |
50 mg |
EUR 1634 |
|
|
|
Description: A variety of cyanine dyes has been used to label biological molecules for fluorescence imaging and other fluorescence-based biochemical analysis. |
Sulfo-Cyanine 5 NHS ester |
|
268 |
AAT Bioquest |
10 mg |
EUR 570 |
|
Description: A variety of cyanine dyes has been used to label biological molecules for fluorescence imaging and other fluorescence-based biochemical analysis. |
Sulfo-Cyanine 5 NHS ester |
|
268-10mg |
AAT Bioquest |
10 mg |
EUR 558 |
|
|
|
Description: A variety of cyanine dyes has been used to label biological molecules for fluorescence imaging and other fluorescence-based biochemical analysis. |
Sulfo-Cyanine 5 NHS ester |
|
269 |
AAT Bioquest |
50 mg |
EUR 1667 |
|
Description: A variety of cyanine dyes has been used to label biological molecules for fluorescence imaging and other fluorescence-based biochemical analysis. |
Sulfo-Cyanine 5 NHS ester |
|
269-50mg |
AAT Bioquest |
50 mg |
EUR 1634 |
|
|
|
Description: A variety of cyanine dyes has been used to label biological molecules for fluorescence imaging and other fluorescence-based biochemical analysis. |
NHS-LC-LC-Biotin |
|
A8017-100 |
ApexBio |
100mg |
EUR 120 |
Sulfo-LC-SPDP |
|
2325-250 |
Biovision |
each |
EUR 1880.4 |
Sulfo-LC-SPDP |
|
2325-50 |
Biovision |
each |
EUR 523.2 |
Sulfo-LC-SPDP |
|
HY-126495 |
MedChemExpress |
10 mg |
EUR 229.44 |
|
Description: Sulfo-LC-SPDP is a heterobifunctional, thiol-cleavable and membrane impermeable crosslinker. |
Sulfo-NHS Acetate |
|
21960001-1 |
Bio-WORLD |
100 mg |
EUR 162.04 |
|
|
Sulfo-NHS-Acetate |
|
HY-140341 |
MedChemExpress |
100 mg |
EUR 114.72 |
|
Description: Sulfo-NHS-Acetate is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1]. |
Sulfo-NHS-Acetate |
|
T16959-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-Acetate |
Sulfo-NHS-Acetate |
|
T16959-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
|
|
Description: Sulfo-NHS-Acetate |
Sulfo-NHS-Acetate |
|
T16959-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-Acetate |
Sulfo-NHS-Acetate |
|
T16959-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-Acetate |
Sulfo-NHS-Acetate |
|
T16959-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
|
|
Description: Sulfo-NHS-Acetate |
Sulfo-Cyanine7 NHS ester, 25 mg |
|
45320 |
Lumiprobe |
25 mg |
EUR 615.6 |
Sulfo-Cyanine3 NHS ester, 50 mg |
|
51320 |
Lumiprobe |
50 mg |
EUR 1105.2 |
Sulfo-Cyanine5 NHS ester, 5 mg |
|
23320 |
Lumiprobe |
5 mg |
EUR 280.8 |
Sulfo-Cyanine3 NHS ester, 100 mg |
|
61320 |
Lumiprobe |
100 mg |
EUR 1711.2 |
sulfo-Cyanine3.5 NHS ester, 100 mg |
|
62320 |
Lumiprobe |
100 mg |
EUR 1711.2 |
Sulfo-Cyanine5 NHS ester, 100 mg |
|
63320 |
Lumiprobe |
100 mg |
EUR 1711.2 |
Sulfo-Cyanine7 NHS ester, 100 mg |
|
65320 |
Lumiprobe |
100 mg |
EUR 1711.2 |
Sulfo-Cyanine7.5 NHS ester, 100 mg |
|
66320 |
Lumiprobe |
100 mg |
EUR 1711.2 |
Sulfo-Cyanine7 NHS ester, 1 mg |
|
15320 |
Lumiprobe |
1 mg |
EUR 129.6 |
Sulfo-Cyanine7.5 NHS ester, 1 mg |
|
16320 |
Lumiprobe |
1 mg |
EUR 129.6 |
NHS-LC-Biotin |
|
A8004-100 |
ApexBio |
100 mg |
EUR 48 |
|
|
|
Description: Biotinylation Reagents|Amine Biotinylation Reagents |
NHS-LC-Biotin |
|
A8004-1000 |
ApexBio |
1 g |
EUR 657.6 |
|
Description: NHS-LC-biotin (succinimidyl-6-(biotinamindo)hexanoate), also known as NHS-X-biotin is a derivative of D-biotin, a amine-reactive biotinylation agent, that contains a spacer arm off the valeric acid side chain of D-biotin with an NHS ester group at its end. |
Sulfo-NHS-Biotin Kit (90-180 kDa) |
|
K1151-10 |
ApexBio |
10samples |
EUR 256 |
|
Description: Biotinylation reagents and kits |
Sulfo-NHS-Biotin Kit (90-180 kDa) |
|
K1151-3 |
ApexBio |
3samples |
EUR 101.6 |
|
Description: Biotinylation reagents and kits |
Sulfo-NHS-Biotin Kit (30-90 kDa) |
|
K1152-10 |
ApexBio |
10samples |
EUR 256 |
|
Description: Biotinylation reagents and kits |
Sulfo-NHS-Biotin Kit (30-90 kDa) |
|
K1152-3 |
ApexBio |
3samples |
EUR 101.6 |
|
Description: Biotinylation reagents and kits |
Sulfo-NHS-Biotin Kit (10-20 kDa) |
|
K1153-10 |
ApexBio |
10samples |
EUR 256 |
|
Description: Biotinylation reagents and kits |
Sulfo-NHS-Biotin Kit (10-20 kDa) |
|
K1153-3 |
ApexBio |
3samples |
EUR 101.6 |
|
Description: Biotinylation reagents and kits |
Sulfo-LC-SPDP (sodium) |
|
HY-126495A |
MedChemExpress |
10 mg |
EUR 229.44 |
|
Description: Sulfo-LC-SPDP sodium is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1]. |
Sulfo-NHS-Acetate (sodium) |
|
HY-140341A |
MedChemExpress |
1 mg |
EUR 454.55 |
|
Description: Sulfo-NHS-Acetate sodium is an alkyl chain-based PROTAC linker. Sulfo-NHS-Acetate sodium can be used in the synthesis of PROTACs[1]. |
Sulfosuccinimidyl 3-[[2-(Biotinamido)ethyl] dithio]propionate (NHS-SS-BIOTIN) |
|
MBS6029521-100mg |
MyBiosource |
100mg |
EUR 620 |
Sulfosuccinimidyl 3-[[2-(Biotinamido)ethyl] dithio]propionate (NHS-SS-BIOTIN) |
|
MBS6029521-25mg |
MyBiosource |
25(mg |
EUR 425 |
Sulfosuccinimidyl 3-[[2-(Biotinamido)ethyl] dithio]propionate (NHS-SS-BIOTIN) |
|
MBS6029521-50mg |
MyBiosource |
50mg |
EUR 525 |
Sulfosuccinimidyl 3-[[2-(Biotinamido)ethyl] dithio]propionate (NHS-SS-BIOTIN) |
|
MBS6029521-5x100mg |
MyBiosource |
5x100(mg |
EUR 2635 |
Biotin-PEG?-NHS |
|
B1518-250 |
Biovision |
each |
EUR 810 |
NHS-LC-Biotin Kit |
|
K1003-10 |
ApexBio |
10 reactions |
EUR 181.6 |
|
|
|
Description: Biotinylation Reagents|Amine Biotinylation Reagents#Labels and tags|Biotinylation Reagents |
Vinblastine, Sulfate Salt [CAS# 143-67-9] |
|
V-7300 |
LC LABORATORIES |
10 mg |
EUR 39 |
LC-LC(+)-Biotin |
|
abx184150-5g |
Abbexa |
5 g |
EUR 1195.2 |
|
|
6-Maleimidocaproic acid sulfo-NHS |
|
HY-136158 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: 6-Maleimidocaproic acid sulfo-NHS is an alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs[1]. |
6-Maleimidocaproic acid sulfo-NHS |
|
MBS5799093-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
6-Maleimidocaproic acid sulfo-NHS |
|
T38440-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
|
|
Description: 6-Maleimidocaproic acid sulfo-NHS |
The comparability of typical MR imaging and artificial MRI confirmed good correlation within the supratentorial area of the mind (κ = 0.82-1). Mechanically segmented mind parenchymal quantity, intracranial quantity, and GM volumes have been considerably elevated within the sufferers with neurofibromatosis sort 1 (P < .05). The myelin-correlated compound, myelin fraction quantity, WM fraction quantity, transverse leisure charge, and longitudinal leisure charge values have been considerably decreased in focal areas of sign depth on myelin and WM maps (P < .001); nevertheless, GM, GM fraction quantity, and proton density values have been considerably elevated on the GM map (P < .001).